The MarketWatch News Department was not involved in the creation of this content. Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development ...
A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform. Subscribe to our newsletter for the latest sci-tech news updates ...
Invivyd, Inc. announced new in vitro data demonstrating that its investigational monoclonal antibody PEMGARDA™ (pemivibart) continues to show consistent neutralizing activity against the dominant SARS ...
KP.3.1.1 and LB.1 in vitro neutralization potency values now reflected in the PEMGARDA Fact Sheet for Healthcare Providers are in-line with prior variants, including variants represented in the CANOPY ...
Most notably, in vitro neutralization assays found significant increases in milk- and plasma-derived IgG neutralization efficacy, with estimated 60% and 90% improvements, respectively. Validating ...
A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform. The platform uses respiratory organoids that adequately model ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results